2022 Advanced Accreditation Series - Cybersecurity
This activity will provide the participants an opportunity to learn from experts in the field. The series will provide examples of the challenges, successful implementation and mitigation strategies for cybersecurity regulatory / accreditation rules and standards as well as how to drill down to uncover the barriers to being successful and how to maintain the gains.
1. Identify the intent of cybersecurity regulatory/accreditation requirements.
2. Describe a current process to meet cybersecurity regulatory / accreditation requirements
3. Develop recommended strategies for successful cybersecurity regulatory/accreditation issues.
4. Describe how addressing cybersecurity regulatory / accreditation requirements using a recommended strategy positions an organization for effective and reliable delivery of safe, high quality patient care.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Absence of Relevant Financial Relationships
The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.
Planning committee members
Natalie Webb, MHA, RN, CPHQ
Diana Scott, MHA, RN, CPHQ
Associate VP Accreditation Advisory Services
Joseph Bellino, MS CHPA, HEM
Randy Gerwitz, RPh
Sr. Consulting Solutions Director, Pharmacy
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity is designated for 1.50 contact hours.
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.50 contact hours.
NATIONAL ASSOCIATION FOR HEALTHCARE QUALITY
This program has been approved by the National Association for Healthcare Quality for a maximum of 1.50 CPHQ continuing education credits for this event.
Certificate of attendance
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
- 1.50 ANCC
- 1.50 CBRN
- 1.50 CPHQ – Certified Professional Healthcare Quality
- 1.50 General CE – Attendance